Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 07.11.2024
Ekosem-Agrar AG
Ekosem-Agrar AG: Deferral of interest payment due on 7 December 2024 and progress in bond restructuring
Deferral of interest payment due on 7 December 2024 to the noteholders of the Ekosem-Agrar bond 2012/2027
Advanced and constructive talks on the sale of company holdings to Russia
Walldorf, 7 November 2024 – Ekosem-Agrar AG, the German holding [ … ]
Thu, 07.11.2024
ZenaTech Inc.
TORONTO, Ontario – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise SaaS (Software-as-a-Service) solutions, announces that company principals are currently participating in a Trade Mission to Taipei, Taiwan as part of an Arizona Commerce Authority [ … ]
Thu, 07.11.2024
JPMorgan ETFs (Ireland) ICAV
COMPANY ANNOUNCEMENT
For Immediate Release
07 November 2024
JPMorgan ETFs (Ireland) ICAV
RE: Dividends
The Directors of JPMorgan ETFs (Ireland) ICAV (the "Company") wish to announce the following dividends which are ex dividend as of the 14 November 2024, record date as of the 15 No [ … ]
Thu, 07.11.2024
123fahrschule SE
Update: Amendment to driving school training
Implementation and digitization process continues despite coalition rupture
Cologne, November 07, 2024 - 123fahrschule SE (ISIN: DE000A2P4HL9; ticker symbol: 123F, primary market Düsseldorf Stock Exchange), a digitally driven driving school chain in Germany with a focus on e-learning and digital tra [ … ]
Thu, 07.11.2024
CureVac
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
TÜBINGEN, Germany/BOSTON, USA – November 7, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), will r [ … ]
Thu, 07.11.2024
Immunic AG
Immunic, Inc. Reports Third Quarter 2024 Financial Results
and Provides Corporate Update
– Positive Interim Analysis of Phase 3 ENSURE Program, Unblinded Independent Data Monitoring Committee Confirmed that Predetermined Futility Criteria Have Not Been Met and Recommended Trials Should Continue as Planned –
– Ongoing, Twin Phase 3 ENSURE Trials [ … ]
Thu, 07.11.2024
Birkenstock Holding plc
PRESS RELEASE
LONDON, UNITED KINGDOM || NOVEMBER 7, 2024
BIRKENSTOCK ANNOUNCES FOURTH QUARTER AND FULL FISCAL YEAR 2024 (ENDED SEPTEMBER 30, 2024) RESULTS DATE AND CONFERENCE CALL
Birkenstock Holding plc (“BIRKENSTOCK” or the “Company”, NYSE: BIRK), announced today that the Company will report its fourth quarter and full fiscal year 2024 (end [ … ]
Thu, 07.11.2024
ELARIS AG
ELARIS AG strengthens internal structures to enable further growth / Steffen Cost named Chief Commercial Officer (CCO)
Bad Dürkheim, November 7, 2024 - ELARIS AG (“ELARIS,” ISIN DE000A37FT17) is expanding its internal structures to facilitate further international growth. With Steffen Cost, a renowned expert from the automotive industry was signe [ … ]
Thu, 07.11.2024
The NAGA Group AG
The NAGA Group AG collaborates with sports icon Mike Tyson as new brand ambassadorHamburg, 7 November 2024 – The NAGA Group AG (XETRA: N4G, ISIN: DE000A161NR7), provider of the all-in-one financial SuperApp NAGA, is pleased to announce the launch of its latest campaign, “NAGA: Your Go-to App for Everything Money”, featuring legendary sports icon Mi [ … ]
Thu, 07.11.2024
Cenit AG
Company Name:
Cenit AG
ISIN:
DE0005407100
Reason for the research:
Research Comment
Recommendation:
Buy
Target price:
EUR 22.00
Target price on sight of:
31.12.2025
Last rating change:
Analyst:
Cosmin Filker, Marcel Goldmann
You can download the research here: http://www.more-ir.de/d/31203.pdf
Contact for questions:
++++++++ [ … ]